Seelos Therapeutics, Inc. Deferred Offering Costs
Seelos Therapeutics, Inc. had Deferred Offering Costs of $253.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2022-08-05
- 2022-06-30: Deferred Offering Costs $253.00K.
- 2019-12-31: Deferred Offering Costs $0.00.
- 2019-09-30: Deferred Offering Costs $0.00.
- 2019-06-30: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2022-06-30 | $253.00K 10-Q · filed 2022-08-05 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-17 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-21 |
| 2018-12-31 | $140.00K 10-K · filed 2020-03-17 |